Pulmonary Drug Delivery Systems Market - Global Outlook and Forecast 2021-2027

March 2021 | 100 pages | ID: P9C53D0B21FAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pulmonary Drug Delivery Systems in global, including the following market information:

Global Pulmonary Drug Delivery Systems Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Pulmonary Drug Delivery Systems Market Sales, 2016-2021, 2022-2027, (M Units)

Global top five Pulmonary Drug Delivery Systems companies in 2020 (%)

The global Pulmonary Drug Delivery Systems market was valued at 3007.9 million in 2020 and is projected to reach US$ 3521.5 million by 2027, at a CAGR of 4.0% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pulmonary Drug Delivery Systems Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Type, 2020 (%)

• Nebulizers
• Dry Powder Inhaler (DPI)
• Metered Dose Inhaler (MDI)

Global Pulmonary Drug Delivery Systems Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Application, 2020 (%)

• COPD
• Asthma
• Others

Global Pulmonary Drug Delivery Systems Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Units)

Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pulmonary Drug Delivery Systems revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Pulmonary Drug Delivery Systems revenues share in global market, 2020 (%)

Key companies Pulmonary Drug Delivery Systems sales in global market, 2016-2021 (Estimated), (M Units)

Key companies Pulmonary Drug Delivery Systems sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3M
• GSK
• AstraZeneca
• Cipla
• Chiesi
• Boehringer Ingelheim
• Aptar
• Novartis
• Philips Respironics
• Omron Healthcare
• PARI
• Skyepharma
• CareFusion
• Shanghai Huarui
• Taian Character
• Chia Tai Tianqing

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pulmonary Drug Delivery Systems Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS OVERALL MARKET SIZE

2.1 Global Pulmonary Drug Delivery Systems Market Size: 2021 VS 2027
2.2 Global Pulmonary Drug Delivery Systems Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pulmonary Drug Delivery Systems Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Pulmonary Drug Delivery Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Systems Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Systems Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pulmonary Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Players in Global Market
  3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Systems Companies
  3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pulmonary Drug Delivery Systems Market Size Markets, 2021 & 2027
  4.1.2 Nebulizers
  4.1.3 Dry Powder Inhaler (DPI)
  4.1.4 Metered Dose Inhaler (MDI)
4.2 By Type - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
  4.2.1 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2016-2021
  4.2.2 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2022-2027
  4.2.3 By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
4.3 By Type - Global Pulmonary Drug Delivery Systems Sales & Forecasts
  4.3.1 By Type - Global Pulmonary Drug Delivery Systems Sales, 2016-2021
  4.3.2 By Type - Global Pulmonary Drug Delivery Systems Sales, 2022-2027
  4.3.3 By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
4.4 By Type - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2027
  5.1.2 COPD
  5.1.3 Asthma
  5.1.4 Others
5.2 By Application - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
  5.2.1 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2016-2021
  5.2.2 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2022-2027
  5.2.3 By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
5.3 By Application - Global Pulmonary Drug Delivery Systems Sales & Forecasts
  5.3.1 By Application - Global Pulmonary Drug Delivery Systems Sales, 2016-2021
  5.3.2 By Application - Global Pulmonary Drug Delivery Systems Sales, 2022-2027
  5.3.3 By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
5.4 By Application - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2027
6.2 By Region - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
  6.2.1 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2016-2021
  6.2.2 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2022-2027
  6.2.3 By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
6.3 By Region - Global Pulmonary Drug Delivery Systems Sales & Forecasts
  6.3.1 By Region - Global Pulmonary Drug Delivery Systems Sales, 2016-2021
  6.3.2 By Region - Global Pulmonary Drug Delivery Systems Sales, 2022-2027
  6.3.3 By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Pulmonary Drug Delivery Systems Revenue, 2016-2027
  6.4.2 By Country - North America Pulmonary Drug Delivery Systems Sales, 2016-2027
  6.4.3 US Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.4.4 Canada Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.4.5 Mexico Pulmonary Drug Delivery Systems Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Pulmonary Drug Delivery Systems Revenue, 2016-2027
  6.5.2 By Country - Europe Pulmonary Drug Delivery Systems Sales, 2016-2027
  6.5.3 Germany Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.4 France Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.5 U.K. Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.6 Italy Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.7 Russia Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.8 Nordic Countries Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.5.9 Benelux Pulmonary Drug Delivery Systems Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Pulmonary Drug Delivery Systems Revenue, 2016-2027
  6.6.2 By Region - Asia Pulmonary Drug Delivery Systems Sales, 2016-2027
  6.6.3 China Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.6.4 Japan Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.6.5 South Korea Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.6.6 Southeast Asia Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.6.7 India Pulmonary Drug Delivery Systems Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Pulmonary Drug Delivery Systems Revenue, 2016-2027
  6.7.2 By Country - South America Pulmonary Drug Delivery Systems Sales, 2016-2027
  6.7.3 Brazil Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.7.4 Argentina Pulmonary Drug Delivery Systems Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, 2016-2027
  6.8.3 Turkey Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.8.4 Israel Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.8.5 Saudi Arabia Pulmonary Drug Delivery Systems Market Size, 2016-2027
  6.8.6 UAE Pulmonary Drug Delivery Systems Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 3M
  7.1.1 3M Corporate Summary
  7.1.2 3M Business Overview
  7.1.3 3M Pulmonary Drug Delivery Systems Major Product Offerings
  7.1.4 3M Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.1.5 3M Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Pulmonary Drug Delivery Systems Major Product Offerings
  7.2.4 GSK Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.2.5 GSK Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Pulmonary Drug Delivery Systems Major Product Offerings
  7.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.3.5 AstraZeneca Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla Pulmonary Drug Delivery Systems Major Product Offerings
  7.4.4 Cipla Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.4.5 Cipla Key News
7.5 Chiesi
  7.5.1 Chiesi Corporate Summary
  7.5.2 Chiesi Business Overview
  7.5.3 Chiesi Pulmonary Drug Delivery Systems Major Product Offerings
  7.5.4 Chiesi Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.5.5 Chiesi Key News
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Corporate Summary
  7.6.2 Boehringer Ingelheim Business Overview
  7.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Major Product Offerings
  7.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.6.5 Boehringer Ingelheim Key News
7.7 Aptar
  7.7.1 Aptar Corporate Summary
  7.7.2 Aptar Business Overview
  7.7.3 Aptar Pulmonary Drug Delivery Systems Major Product Offerings
  7.4.4 Aptar Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.7.5 Aptar Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Pulmonary Drug Delivery Systems Major Product Offerings
  7.8.4 Novartis Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.8.5 Novartis Key News
7.9 Philips Respironics
  7.9.1 Philips Respironics Corporate Summary
  7.9.2 Philips Respironics Business Overview
  7.9.3 Philips Respironics Pulmonary Drug Delivery Systems Major Product Offerings
  7.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.9.5 Philips Respironics Key News
7.10 Omron Healthcare
  7.10.1 Omron Healthcare Corporate Summary
  7.10.2 Omron Healthcare Business Overview
  7.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Major Product Offerings
  7.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.10.5 Omron Healthcare Key News
7.11 PARI
  7.11.1 PARI Corporate Summary
  7.11.2 PARI Pulmonary Drug Delivery Systems Business Overview
  7.11.3 PARI Pulmonary Drug Delivery Systems Major Product Offerings
  7.11.4 PARI Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.11.5 PARI Key News
7.12 Skyepharma
  7.12.1 Skyepharma Corporate Summary
  7.12.2 Skyepharma Pulmonary Drug Delivery Systems Business Overview
  7.12.3 Skyepharma Pulmonary Drug Delivery Systems Major Product Offerings
  7.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.12.5 Skyepharma Key News
7.13 CareFusion
  7.13.1 CareFusion Corporate Summary
  7.13.2 CareFusion Pulmonary Drug Delivery Systems Business Overview
  7.13.3 CareFusion Pulmonary Drug Delivery Systems Major Product Offerings
  7.13.4 CareFusion Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.13.5 CareFusion Key News
7.14 Shanghai Huarui
  7.14.1 Shanghai Huarui Corporate Summary
  7.14.2 Shanghai Huarui Business Overview
  7.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Major Product Offerings
  7.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.14.5 Shanghai Huarui Key News
7.15 Taian Character
  7.15.1 Taian Character Corporate Summary
  7.15.2 Taian Character Business Overview
  7.15.3 Taian Character Pulmonary Drug Delivery Systems Major Product Offerings
  7.15.4 Taian Character Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.15.5 Taian Character Key News
7.16 Chia Tai Tianqing
  7.16.1 Chia Tai Tianqing Corporate Summary
  7.16.2 Chia Tai Tianqing Business Overview
  7.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Major Product Offerings
  7.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales and Revenue in Global (2016-2021)
  7.16.5 Chia Tai Tianqing Key News

8 GLOBAL PULMONARY DRUG DELIVERY SYSTEMS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Pulmonary Drug Delivery Systems Production Capacity, 2016-2027
8.2 Pulmonary Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Systems Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PULMONARY DRUG DELIVERY SYSTEMS SUPPLY CHAIN ANALYSIS

10.1 Pulmonary Drug Delivery Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Systems Upstream Market
10.3 Pulmonary Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Pulmonary Drug Delivery Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Systems Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pulmonary Drug Delivery Systems Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pulmonary Drug Delivery Systems Revenue Share by Companies, 2016-2021
Table 5. Global Pulmonary Drug Delivery Systems Sales by Companies, (M Units), 2016-2021
Table 6. Global Pulmonary Drug Delivery Systems Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pulmonary Drug Delivery Systems Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Pulmonary Drug Delivery Systems Sales (M Units), 2016-2021
Table 15. By Type - Global Pulmonary Drug Delivery Systems Sales (M Units), 2022-2027
Table 16. By Application – Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Pulmonary Drug Delivery Systems Sales (M Units), 2016-2021
Table 20. By Application - Global Pulmonary Drug Delivery Systems Sales (M Units), 2022-2027
Table 21. By Region – Global Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Pulmonary Drug Delivery Systems Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Pulmonary Drug Delivery Systems Sales (M Units), 2016-2021
Table 25. By Region - Global Pulmonary Drug Delivery Systems Sales (M Units), 2022-2027
Table 26. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Pulmonary Drug Delivery Systems Sales, (M Units), 2016-2021
Table 29. By Country - North America Pulmonary Drug Delivery Systems Sales, (M Units), 2022-2027
Table 30. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Pulmonary Drug Delivery Systems Sales, (M Units), 2016-2021
Table 33. By Country - Europe Pulmonary Drug Delivery Systems Sales, (M Units), 2022-2027
Table 34. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Pulmonary Drug Delivery Systems Sales, (M Units), 2016-2021
Table 37. By Region - Asia Pulmonary Drug Delivery Systems Sales, (M Units), 2022-2027
Table 38. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Pulmonary Drug Delivery Systems Sales, (M Units), 2016-2021
Table 41. By Country - South America Pulmonary Drug Delivery Systems Sales, (M Units), 2022-2027
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (M Units), 2016-2021
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, (M Units), 2022-2027
Table 46. 3M Corporate Summary
Table 47. 3M Pulmonary Drug Delivery Systems Product Offerings
Table 48. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. GSK Corporate Summary
Table 50. GSK Pulmonary Drug Delivery Systems Product Offerings
Table 51. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. AstraZeneca Corporate Summary
Table 53. AstraZeneca Pulmonary Drug Delivery Systems Product Offerings
Table 54. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Cipla Corporate Summary
Table 56. Cipla Pulmonary Drug Delivery Systems Product Offerings
Table 57. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Chiesi Corporate Summary
Table 59. Chiesi Pulmonary Drug Delivery Systems Product Offerings
Table 60. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Offerings
Table 63. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Aptar Corporate Summary
Table 65. Aptar Pulmonary Drug Delivery Systems Product Offerings
Table 66. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Novartis Corporate Summary
Table 68. Novartis Pulmonary Drug Delivery Systems Product Offerings
Table 69. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Philips Respironics Corporate Summary
Table 71. Philips Respironics Pulmonary Drug Delivery Systems Product Offerings
Table 72. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Omron Healthcare Corporate Summary
Table 74. Omron Healthcare Pulmonary Drug Delivery Systems Product Offerings
Table 75. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. PARI Corporate Summary
Table 77. PARI Pulmonary Drug Delivery Systems Product Offerings
Table 78. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Skyepharma Corporate Summary
Table 80. Skyepharma Pulmonary Drug Delivery Systems Product Offerings
Table 81. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. CareFusion Corporate Summary
Table 83. CareFusion Pulmonary Drug Delivery Systems Product Offerings
Table 84. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 85. Shanghai Huarui Corporate Summary
Table 86. Shanghai Huarui Pulmonary Drug Delivery Systems Product Offerings
Table 87. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 88. Taian Character Corporate Summary
Table 89. Taian Character Pulmonary Drug Delivery Systems Product Offerings
Table 90. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 91. Chia Tai Tianqing Corporate Summary
Table 92. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Offerings
Table 93. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 94. Pulmonary Drug Delivery Systems Production Capacity (M Units) of Key Manufacturers in Global Market, 2019-2021 (M Units)
Table 95. Global Pulmonary Drug Delivery Systems Capacity Market Share of Key Manufacturers, 2019-2021
Table 96. Global Pulmonary Drug Delivery Systems Production by Region, 2016-2021 (M Units)
Table 97. Global Pulmonary Drug Delivery Systems Production by Region, 2022-2027 (M Units)
Table 98. Pulmonary Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 99. Pulmonary Drug Delivery Systems Market Drivers in Global Market
Table 100. Pulmonary Drug Delivery Systems Market Restraints in Global Market
Table 101. Pulmonary Drug Delivery Systems Raw Materials
Table 102. Pulmonary Drug Delivery Systems Raw Materials Suppliers in Global Market
Table 103. Typical Pulmonary Drug Delivery Systems Downstream
Table 104. Pulmonary Drug Delivery Systems Downstream Clients in Global Market
Table 105. Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Pulmonary Drug Delivery Systems Segment by Type
Figure 2. Pulmonary Drug Delivery Systems Segment by Application
Figure 3. Global Pulmonary Drug Delivery Systems Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Systems Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Systems Revenue, 2016-2027 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Systems Sales in Global Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Systems Revenue in 2020
Figure 9. By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 10. By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 11. By Type - Global Pulmonary Drug Delivery Systems Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 13. By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 14. By Application - Global Pulmonary Drug Delivery Systems Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 16. By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 17. By Country - North America Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 18. By Country - North America Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 19. US Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 24. Germany Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 25. France Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 33. China Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 37. India Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 39. By Country - South America Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 40. Brazil Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales Market Share, 2016-2027
Figure 44. Turkey Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Pulmonary Drug Delivery Systems Revenue, (US$, Mn), 2016-2027
Figure 48. Global Pulmonary Drug Delivery Systems Production Capacity (M Units), 2016-2027
Figure 49. The Percentage of Production Pulmonary Drug Delivery Systems by Region, 2020 VS 2027
Figure 50. Pulmonary Drug Delivery Systems Industry Value Chain
Figure 51. Marketing Channels